-
This is a blatant and shameful attempt to intimidate groups who will be working to inform Americans about their new health insurance options and help them enroll in coverage, says one spokeswoman.
September 3 -
A recent delay on out-of-pocket spending could be complicated for those who think they have a single-vendor system, should their health care provider and pharmacy be considered separate internally.
September 3 -
Supporters of the U.S. health care overhaul are criticizing a House panels scrutiny of nonprofit groups set to help enroll people in new insurance plans, saying its part of a Republican effort to impede the law.
September 3 -
The U.S. Department of Labor has provided guidance on Family and Medical Leave Act protections for same-sex couples. The guidance follows the U.S. Supreme Courts decision to strike down Section 3 of the Defense of Marriage Act, which fundamentally changed how the federal government treats same-sex marriages.
August 30 -
Despite the modest increase rising health care costs remain a serious concern for U.S. employers, said Helen Darling, the groups president and CEO.
August 29 -
With 33 days and counting until online health insurance exchanges must open for business, states are racing to fine-tune computer systems, educate consumers and manage expectations.
August 29 -
The number of Fortune 500 companies offering health care benefits to same-sex partners has surged in a decade, to about 62% last year from 34% in 2002, according to the Washington-based Human Rights Campaign.
August 28 -
More than a third of survey respondents plan to make a change to their HR structure before the end of 2014. Towers Watson says that among those organizations planning change, 74% say its to improve operational efficiencies.
August 28 -
A new poll shows a large gap between the amount of life insurance necessary and what consumers think they have.
August 28 -
The bill passed Monday would require pharmacies to notify doctors and sometimes patients when a cheaper biosimilar drug is substituted for a brand-name medicine. It also would forbid a pharmacist from substituting the biosimilar drug if the physician says no.
August 27

